[HTML][HTML] Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation
With rapid advances in modern imaging, minimally invasive ablative procedures have
emerged as popular alternatives to surgical removal of tumors. Tumor ablation modalities …
emerged as popular alternatives to surgical removal of tumors. Tumor ablation modalities …
[HTML][HTML] Cryoablation and immune synergistic effect for lung cancer: A review
Y Tian, X Qi, X Jiang, L Shang, K Xu… - Frontiers in …, 2022 - frontiersin.org
The preferred treatment for lung cancer is surgical resection, but a large number of patients
are not suitable for surgical resection in clinic. CT-guided cryoablation and immunotherapy …
are not suitable for surgical resection in clinic. CT-guided cryoablation and immunotherapy …
Comparison of percutaneous image-guided microwave ablation and cryoablation for sarcoma lung metastases: a 10-year experience
PP Bourgouin, MM Wrobel… - American Journal of …, 2022 - Am Roentgen Ray Soc
Please see the Editorial Comment by Nassir Rostambeigi discussing this article.
BACKGROUND. To our knowledge, outcomes between percutaneous microwave ablation …
BACKGROUND. To our knowledge, outcomes between percutaneous microwave ablation …
[HTML][HTML] Transbronchial techniques for lung cancer treatment: where are we now?
JWY Chan, ICH Siu, ATC Chang, MSC Li, RWH Lau… - Cancers, 2023 - mdpi.com
Simple Summary Traditionally, local treatment of lung cancers mainly consists of three
branches: surgical resection, radiotherapy, and percutaneous ablation. With the advent of …
branches: surgical resection, radiotherapy, and percutaneous ablation. With the advent of …
[HTML][HTML] Current management of oligometastatic lung cancer and future perspectives: results of thermal ablation as a local ablative therapy
M Ghosn, SB Solomon - Cancers, 2021 - mdpi.com
Simple Summary Up to 56% of lung cancer patients present with metastatic disease at initial
diagnosis. Whereas these patients were historically deemed incurable, recent evidence …
diagnosis. Whereas these patients were historically deemed incurable, recent evidence …
Percutaneous image-guided thermal ablation of lung cancer: What is the evidence?
EC Bartlett, S Rahman, CA Ridge - Lung Cancer, 2023 - Elsevier
Thermal ablation techniques have now been used for more than twenty years in the
treatment of primary lung tumours, predominantly non-small cell lung cancer (NSCLC) …
treatment of primary lung tumours, predominantly non-small cell lung cancer (NSCLC) …
[HTML][HTML] Cutting-Edge Therapies for Lung Cancer
AS La'ah, SH Chiou - Cells, 2024 - mdpi.com
Lung cancer remains a formidable global health challenge that necessitates inventive
strategies to improve its therapeutic outcomes. The conventional treatments, including …
strategies to improve its therapeutic outcomes. The conventional treatments, including …
[HTML][HTML] Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation
J Sang, X Ye - Frontiers in Immunology, 2023 - frontiersin.org
Thermal ablation is a promising alternative treatment for lung cancer. It disintegrates cancer
cells and releases antigens, followed by the remodeling of local tumor immune …
cells and releases antigens, followed by the remodeling of local tumor immune …
Nonsurgical therapy for early-stage lung cancer
ME Daly, P Beagen, MH Madani - Hematology/Oncology …, 2023 - hemonc.theclinics.com
The standard treatment for early-stage non-small cell lung cancer (NSCLC) has historically
been surgical, through either lobectomy or sublobar resection. However, many patients with …
been surgical, through either lobectomy or sublobar resection. However, many patients with …
Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review
Lung cancer continues to be the most common cause of cancer-related death worldwide. In
the past decade, with the implementation of lung cancer screening programs and advances …
the past decade, with the implementation of lung cancer screening programs and advances …